Global Physician Dispensed Cosmeceuticals Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

PUBLISHED: July 1, 2024

PAGES: 128 Pages

DELIVERY TIME: 1-2 business days

ADD TO COMPARE

SELECT AN OPTION

The global demand for Physician Dispensed Cosmeceuticals Market is presumed to reach the market size of nearly USD 23.33 Billion by 2032 from USD 11.33 Billion in 2023 with a CAGR of 8.35% under the study period 2024-2032.

Physician dispensed cosmeceuticals refer to the various cosmetic products recommended by physicals that are specially compounded to offer heightened results with or without other treatments, such as surgery or Botox. These products differ from the OTC counterparts in the way they are formulated and their quality and strength. Physician-grade cosmeceuticals contain more substantial concentrations of peptides and Vitamin C. The concentration and delivery of peptides have a more significant impact on the appearance of the skin by encouraging better fibroblast activity or collagen synthesis. With the knowledgeable guidance of a licensed skincare professional, they offer far more versatility to match a patient's skin, condition, and lifestyle. They come in various strengths, formulations, and concentrations to fit all different skin types and requirements.

MARKET DYNAMICS

The significant growth in the demand for skincare and patients beginning to rely on dermatologists and cosmetic physicians to recommend suitable products for their skin, hair, and nails will be the main trending factors for physician-dispensed cosmeceuticals. The rising levels of stress and pollution causing increased damage to the skin, hair, and eyes among the urban population will benefit market growth. Research and development of newer and advanced cosmeceuticals to target several medical conditions will further propel market growth. Various cosmetic startups specializing in the manufacture and marketing of cosmeceuticals, as advised by dermatologists, will positively impact the market. The emergence of the novel concept of herbal medicine will boost the demand for organic physician dispensed cosmeceuticals. High-quality standards set by market leaders and stringent government regulations are few hindrances to the market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Physician Dispensed Cosmeceuticals. The growth and trends of Physician Dispensed Cosmeceuticals industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Physician Dispensed Cosmeceuticals market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product Type

Face-care
Skincare

By Indication

Skin Lightening or De-pigmenting
Rhytide Reduction
Anti-Wrinkle/Aging
Scar-reducing
Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Physician Dispensed Cosmeceuticals market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Physician Dispensed Cosmeceuticals market include AbbVie Inc. (Allergan), L'Oreal S.A., Jan Marini Skin Research Inc., Athena Cosmetics Inc., ZO Skin Health Inc., Galderma Laboratories, L.P., Procter & Gamble Co., The EsteE Lauder Companies Inc., Merz Pharma, Obagi Cosmeceuticals LLC, IS CLINICAL, Neutrogena, Velius LLC, Sonoma Pharmaceuticals Inc., Sientra Inc., Dynamic Techno Medicals, Implantech Associates Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Product Code: VMR11215073

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. PHYSICIAN DISPENSED COSMECEUTICALS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product Type
- 3.7.2 Market Attractiveness Analysis By Indication
- 3.7.3 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL PHYSICIAN DISPENSED COSMECEUTICALS MARKET ANALYSIS BY PRODUCT TYPE

5.1. Overview By Product Type
5.2. Historical and Forecast Data Analysis By Product Type
5.3. Face-care Historic and Forecast Sales By Regions
5.4. Skincare Historic and Forecast Sales By Regions

6. GLOBAL PHYSICIAN DISPENSED COSMECEUTICALS MARKET ANALYSIS BY INDICATION

6.1. Overview By Indication
6.2. Historical and Forecast Data Analysis By Indication
6.3. Skin Lightening or De-pigmenting Historic and Forecast Sales By Regions
6.4. Rhytide Reduction Historic and Forecast Sales By Regions
6.5. Anti-Wrinkle/Aging Historic and Forecast Sales By Regions
6.6. Scar-reducing Historic and Forecast Sales By Regions
6.7. Others Historic and Forecast Sales By Regions

7. GLOBAL PHYSICIAN DISPENSED COSMECEUTICALS MARKET ANALYSIS BY GEOGRAPHY

7.1. Regional Outlook
7.2. Introduction
7.3. North America Sales Analysis
- 7.3.1 Overview, Historic and Forecast Data Sales Analysis
- 7.3.2 North America By Segment Sales Analysis
- 7.3.3 North America By Country Sales Analysis
- 7.3.4 United States Sales Analysis
- 7.3.5 Canada Sales Analysis
- 7.3.6 Mexico Sales Analysis
7.4. Europe Sales Analysis
- 7.4.1 Overview, Historic and Forecast Data Sales Analysis
- 7.4.2 Europe By Segment Sales Analysis
- 7.4.3 Europe By Country Sales Analysis
- 7.4.4 United Kingdom Sales Analysis
- 7.4.5 France Sales Analysis
- 7.4.6 Germany Sales Analysis
- 7.4.7 Italy Sales Analysis
- 7.4.8 Russia Sales Analysis
- 7.4.9 Rest Of Europe Sales Analysis
7.5. Asia Pacific Sales Analysis
- 7.5.1 Overview, Historic and Forecast Data Sales Analysis
- 7.5.2 Asia Pacific By Segment Sales Analysis
- 7.5.3 Asia Pacific By Country Sales Analysis
- 7.5.4 China Sales Analysis
- 7.5.5 India Sales Analysis
- 7.5.6 Japan Sales Analysis
- 7.5.7 South Korea Sales Analysis
- 7.5.8 Australia Sales Analysis
- 7.5.9 South East Asia Sales Analysis
- 7.5.10 Rest Of Asia Pacific Sales Analysis
7.6. Latin America Sales Analysis
- 7.6.1 Overview, Historic and Forecast Data Sales Analysis
- 7.6.2 Latin America By Segment Sales Analysis
- 7.6.3 Latin America By Country Sales Analysis
- 7.6.4 Brazil Sales Analysis
- 7.6.5 Argentina Sales Analysis
- 7.6.6 Peru Sales Analysis
- 7.6.7 Chile Sales Analysis
- 7.6.8 Rest of Latin America Sales Analysis
7.7. Middle East & Africa Sales Analysis
- 7.7.1 Overview, Historic and Forecast Data Sales Analysis
- 7.7.2 Middle East & Africa By Segment Sales Analysis
- 7.7.3 Middle East & Africa By Country Sales Analysis
- 7.7.4 Saudi Arabia Sales Analysis
- 7.7.5 UAE Sales Analysis
- 7.7.6 Israel Sales Analysis
- 7.7.7 South Africa Sales Analysis
- 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE PHYSICIAN DISPENSED COSMECEUTICALS COMPANIES

8.1. Physician Dispensed Cosmeceuticals Market Competition
8.2. Partnership/Collaboration/Agreement
8.3. Merger And Acquisitions
8.4. New Product Launch
8.5. Other Developments

9. COMPANY PROFILES OF PHYSICIAN DISPENSED COSMECEUTICALS INDUSTRY

9.1. Top Companies Market Share Analysis
9.2. Market Concentration Rate
9.3. AbbVie Inc. (Allergan)
- 9.3.1 Company Overview
- 9.3.2 Company Revenue
- 9.3.3 Products
- 9.3.4 Recent Developments
9.4. L'Oreal S.A.
- 9.4.1 Company Overview
- 9.4.2 Company Revenue
- 9.4.3 Products
- 9.4.4 Recent Developments
9.5. Jan Marini Skin Research Inc.
- 9.5.1 Company Overview
- 9.5.2 Company Revenue
- 9.5.3 Products
- 9.5.4 Recent Developments
9.6. Athena Cosmetics Inc.
- 9.6.1 Company Overview
- 9.6.2 Company Revenue
- 9.6.3 Products
- 9.6.4 Recent Developments
9.7. ZO Skin Health Inc.
- 9.7.1 Company Overview
- 9.7.2 Company Revenue
- 9.7.3 Products
- 9.7.4 Recent Developments
9.8. Galderma Laboratories
- 9.8.1 Company Overview
- 9.8.2 Company Revenue
- 9.8.3 Products
- 9.8.4 Recent Developments
9.9. L.P.
- 9.9.1 Company Overview
- 9.9.2 Company Revenue
- 9.9.3 Products
- 9.9.4 Recent Developments
9.10. Procter & Gamble Co.
- 9.10.1 Company Overview
- 9.10.2 Company Revenue
- 9.10.3 Products
- 9.10.4 Recent Developments
9.11. The EsteE Lauder Companies Inc.
- 9.11.1 Company Overview
- 9.11.2 Company Revenue
- 9.11.3 Products
- 9.11.4 Recent Developments
9.12. Merz Pharma
- 9.12.1 Company Overview
- 9.12.2 Company Revenue
- 9.12.3 Products
- 9.12.4 Recent Developments
9.13. Obagi Cosmeceuticals LLC
- 9.13.1 Company Overview
- 9.13.2 Company Revenue
- 9.13.3 Products
- 9.13.4 Recent Developments
9.14. IS CLINICAL
- 9.14.1 Company Overview
- 9.14.2 Company Revenue
- 9.14.3 Products
- 9.14.4 Recent Developments
9.15. Neutrogena
- 9.15.1 Company Overview
- 9.15.2 Company Revenue
- 9.15.3 Products
- 9.15.4 Recent Developments
9.16. Velius LLC
- 9.16.1 Company Overview
- 9.16.2 Company Revenue
- 9.16.3 Products
- 9.16.4 Recent Developments
9.17. Sonoma Pharmaceuticals Inc.
- 9.17.1 Company Overview
- 9.17.2 Company Revenue
- 9.17.3 Products
- 9.17.4 Recent Developments
9.18. Sientra Inc.
- 9.18.1 Company Overview
- 9.18.2 Company Revenue
- 9.18.3 Products
- 9.18.4 Recent Developments
9.19. Dynamic Techno Medicals
- 9.19.1 Company Overview
- 9.19.2 Company Revenue
- 9.19.3 Products
- 9.19.4 Recent Developments
9.20. Implantech Associates Inc
- 9.20.1 Company Overview
- 9.20.2 Company Revenue
- 9.20.3 Products
- 9.20.4 Recent Developments